Medical News

RSS

Public health officials are our COVID commanders. Treat them with respect.

As a veteran who served back-to-back tours in Iraq, I initially cringed when commentators compared the COVID-19 crisis to wartime — no bullets, no blood and no one volunteered for this.

1 Sep 2020

Newly approved drugs in Canada lack key pediatric drug information

Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children's Hospital.

1 Sep 2020

Latest issue of Neurosurgical Focus journal examines anterior approaches to thoracolumbar spinal surgery

The September issue of Neurosurgical Focus looks at anterior approaches to thoracolumbar spinal surgery.

1 Sep 2020

Silicon nitride shows potent SARS-CoV-2 neutralization capability

A new study published on the preprint server bioRxiv* in August 2020 shows that the man-made compound silicon nitride, which is used in medical implants and high mechanical performance engineering applications, is capable of inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at varying concentrations without causing cell cytotoxicity. This finding should be investigated to develop disinfectants to clear the virus from surfaces, preventing its spread.

1 Sep 2020

SAGE and Hindawi sign publishing partnership agreement

SAGE and Hindawi have recently entered into a publishing partnership agreement whereby the latter will publish and develop three SAGE gold open access journals for a period of at least three years.

1 Sep 2020

Human antibody response to SARS-CoV-2

A new study published on the preprint server medRxiv* in August 2020 reports on the human antibody response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which is key to developing vaccines and managing the pandemic, as well as designing and executing serologic testing and interpreting their results.

1 Sep 2020

Warnings can protect memory from misleading information

Warning witnesses about the threat of misinformation - before or after an event - significantly reduces the negative impact of misinformation on memory, according to new research performed at Tufts University.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.

1 Sep 2020

Innovative training protocol leads to real physical and cognitive benefits

Researchers at the Smart-Aging Research Center (IDAC) at Tohoku University have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf,

1 Sep 2020

Patients with cancer and COVID-19 infection can experience blood clots

UC researchers and physicians are learning that COVID-19 impacts more than just the lungs. The list of potential issues multiplies when doctors also consider its impact on patients with other underlying conditions or the medications used to treat those conditions.

1 Sep 2020

Spike ferritin nanoparticles show potential as SARS-CoV-2 vaccine

Now, a new study published on the preprint server bioRxiv* in August 2020 reports the induction of neutralizing antibodies in mice by a single dose of a ferritin nanoparticle-based vaccine containing the spike protein.

1 Sep 2020

Diminished biological arousal before global pandemic may predict PTSD symptoms

People who did not have a large heart rate response to a stress task surprised researchers later -- after the onset of the COVID-19 pandemic -- when they showed more symptoms of post-traumatic stress disorder related to the crisis than others who also did the stress task and COVID-19 stress ratings.

1 Sep 2020

Problematic alcohol use linked to legal performance-enhancing substances

A new study published in the journal Pediatrics found that young adults aged 18-26 who used legal performance-enhancing substances were significantly more likely to report several problematic alcohol use and drinking-related risk behaviors seven years later.

1 Sep 2020

$Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction$

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart failure with preserved ejection fraction

1 Sep 2020

Study: Impact of COVID-19 virus goes far beyond the pulmonary system

Described as a novel, "once-in-a-century" disease, COVID-19 research is evolving to include a growing body of evidence that the virus's impact goes far beyond the pulmonary system.

1 Sep 2020

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

Now, a new study published on the preprint server bioRxiv in August 2020 reports on the identification of 14 compounds that can inhibit the key viral enzyme called the Main Protease (MPro) at micromolar concentrations.

1 Sep 2020

Anonymized cell phone location data can help track new cases of COVID-19

In March 2020, federal officials declared the COVID-19 outbreak a national emergency. Around the same time, most states implemented stay-at-home advisories - to different degrees and at different times.

1 Sep 2020

Rapid COVID-19 test could enable point-of-care diagnosis

As COVID-19 continues to spread, bottlenecks in supplies and laboratory personnel have led to long waiting times for results in some areas.

1 Sep 2020

Researchers propose new reforms to improve transparency of drug authorizations

On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19. On June 15, after a number of studies failed to find positive effects, the agency revoked this authorization.

1 Sep 2020